Skip to content
Evidilya, People & Research First®
Submit an RFP
FULL-SERVICE LIFE-SCIENCES CRODIGITAL-NATIVE ECOSYSTEM

Evidilya, People & Research First®. A digital-native, full-service CRO turning real life into real evidence.

We design and run studies – centralised, hybrid or fully decentralised – that reach the right participants, and turn what they share into evidence that decides.

European by origin · Global by reach
Sponsor-Qualified CROISO 9001 CertifiedEUCROF memberICH E6(R3) GCP / GVP / GDPR compliantPeople & Research First®
Trusted by

Global corporations, challenger brands, scaleups and startups – across pharma, consumer health, nutrition and medtech.

BayerReckitt BenckiserDompéAngeliniPerrigoPierre FabreMenariniUnifarcoNestlé Health ScienceUnileverGiulianiChurch & DwightPepsiCo R&DBoironKanekaLallemandIFF (DuPont Danisco)AlmirallModilacArtsana GroupNovozymesDanoneOpellaGE HealthcareSofibelProbioticalVida PharmaUltragenyxJazz PharmaceuticalsBayerReckitt BenckiserDompéAngeliniPerrigoPierre FabreMenariniUnifarcoNestlé Health ScienceUnileverGiulianiChurch & DwightPepsiCo R&DBoironKanekaLallemandIFF (DuPont Danisco)AlmirallModilacArtsana GroupNovozymesDanoneOpellaGE HealthcareSofibelProbioticalVida PharmaUltragenyxJazz Pharmaceuticals
The truth we build on

Life sciences succeed when they reach people.

People means all of them: participants, the clinicians who see them, and the researchers who turn what happens into evidence.

The right participants are dispersed, rare, or simply not where traditional sites are. Sites deprioritise the study that doesn't fit their flow. And what does get captured scatters across disconnected systems. Recruitment remains the single biggest cause of delay, and no amount of protocol elegance fixes it.

That's why we built a CRO around reach, and gave the method a name – PHYGITAL-CROWD: hospitals, community clinicians, pharmacies and the home, in one governed ecosystem.

We work with GCP centres, community clinicians and pharmacies. If you'd like to run studies with us, start here →

Where we work

One way of building evidence, wherever the question comes from.

Health, nutrition and technology questions rarely stay inside one category, and neither does the evidence that answers them. Across pharma, consumer health, nutrition and medical devices we apply one scientific standard and the same reach into real participants, while the operating model flexes to what each study requires.

One ecosystem. One adaptive operating model. Evidence that keeps its value as your questions move.

See how ECS® connects them
The phygital model

The study travels.
We bring it to the participant.

We build the study around the participant. Phygital means the study flexes to the participant: in-person when the science calls for it, digital when it moves faster, across hospitals, community HCPs, pharmacies, and the home, where qualified nurses and physicians can visit in person.

Direct-to-Participant is not a feature. It is the operating model, the one thing every capability, every domain and every study on ECS® shares.

Direct-to-participant by our founding team, before the market had a name for it · Embraced by today's thriving market
Participant at home reading a study check-in on a smartphone, warm window light.

Physical care where it matters. Digital reach everywhere else.

ONE PARTICIPANT · ONE JOURNEY · ONE SOURCE OF TRUTHHomedigital · hcp in presenceCommunity HCPphysicalPharmacyphysical · onlineHospitalphysicalTelehealthdigital
A community pharmacist handing a blister pack to a patient across a wooden counter.
01
Meet participants where they live.

The study travels to the person, not the other way around, so participation fits an ordinary week.

A single hand holding a smartphone with a soft teal waveform on a dark navy background.
02
One connected ecosystem, end-to-end.

Awareness, consent, data capture and retention run on ECS®, a single source of truth.

A clinician's hands reviewing an abstract data dashboard on a tablet, side profile, teal accent.
03
Evidence-grade by default.

GxP, ICH-GCP, GDPR, engineered in from the start. Evidence-grade by design.

A diverse research team of three collaborating around a wooden table, seen from above.
04
The full arc of research.

From claim advisory to publication and market access, one team, one accountability.

The people behind the evidence

Evidence for life

A patient shares a piece of their life. An investigator listens before measuring. A team turns those moments into evidence that changes decisions, care and outcomes. People at the center of every study. Understood as lives.

Evidilya team and participants, film poster
ECS® · Evidence Capture System

The virtual research ecosystem where the study follows real life.

ECS®, the Evidence Capture System, is Evidilya's virtual research ecosystem: five layers — Engage, Conduct, Capture, Operate, Assure — running a study end to end, from fully remote to hybrid, around the person and the place where care actually happens: at home, at work, in the clinic. The study moves with the protocol and with the life of the people in it, and the Evidence Engine turns what happens into evidence.

EngageConductCaptureOperateAssureEvidence Engine

+ Armonia, patient-community add-on

ECS®, Evidence Capture System
Evidence Capture System
By the numbers

Evidence, at a glance.

01
10
Therapeutic clusters

from cardiometabolic to neuro, oncology to longevity, rare disease runs cross-cutting.

02
4
Domains under one QMS

pharma · consumer health · nutrition · medtech.

03
4 regions
Operational reach

EMEA · APAC · North America · LATAM.

04
60+
Sponsors served

From global leaders to emerging innovators.

Advisory, AI & Insight

AIRA, behind, beyond and above the evidence.

AIRA is Evidilya’s Advisory, AI & Insight practice: strategic intelligence before, around and after every study. It shapes what to prove, how to prove it, and how the result becomes publications, market access and commercialization. It works through three service lines: Advisory, Insight Generation and AI Applied.

  • Advisory
  • Insight Generation
  • AI Applied
RFP starter · 30 seconds

Tell us three things. We'll respond with a scoping call.

A faster way to open a conversation, pick the shape of the study and we'll do the rest.

1 · Capability
2 · Domain
3 · Expected study start

Intro call within 48 business hours.

Where we operate

One connected footprint, across continents.

Ready to generate evidence, faster?

Tell us about your study. We'll show you how ECS® shortens the path from protocol to proof.